Product Information
TOBRADEX EYE OINTMENT is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $89.7774 per GM under NDC 00078087601. Its NADAC has been published 259 times since Jul 14, 2021.
The High Outlier badge above means this manufacturer's average price in the tobramycin and dexamethasone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
1; 3 mg/g; mg/g
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078087601
Classification
Brand
Dosage Form
OINTMENT
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
New Drug (NDA)
FDA Application
NDA050616On Market Since
10/15/1988
Pharmacological Classes
Price Statistics
The NADAC for TOBRADEX EYE OINTMENT has been published 259 times since Jul 14, 2021, and over the history we have for it it has risen 43.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $89.7774 per GM |
|---|---|
| All-time high | $89.7947 (May 13, 2026) |
| All-time low | $62.3983 (Jun 22, 2022) |
| 52-week high | $89.7947 |
| 52-week low | $81.5725 |
| Median price | $72.0243 |
| Average price | $73.4876 |
| Largest weekly change | +9.9% (Jan 22, 2025) |
| Weeks tracked | 259 |
| Tracking since | Jul 14, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the tobramycin and dexamethasone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TOBRADEX EYE OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for TOBRADEX EYE OINTMENT, manufactured by Novartis Pharmaceuticals Corporation, is $89.7774 per GM (NDC 00078087601), effective Jun 24, 2026.
How has the price of TOBRADEX EYE OINTMENT changed over time?
Over the history we have for it, the NADAC for TOBRADEX EYE OINTMENT has risen 43.3%. It has been tracked across 259 weekly CMS publications since Jul 14, 2021.
What are the highest and lowest recorded NADAC prices for TOBRADEX EYE OINTMENT?
Since Jul 14, 2021, the NADAC for TOBRADEX EYE OINTMENT has ranged from a low of $62.3983 (Jun 22, 2022) to a high of $89.7947 (May 13, 2026), with a median of $72.0243 per GM.
Are there cheaper alternatives to TOBRADEX EYE OINTMENT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TOBRADEX EYE OINTMENT, so no direct lower-cost alternative is listed.
Who manufactures TOBRADEX EYE OINTMENT?
TOBRADEX EYE OINTMENT (NDC 00078087601) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification